ArticleJAMA network open2026
Racial, Ethnic, and Socioeconomic Survival Disparities in Early-Onset Metastatic Colorectal Cancer.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Colorectal Cancer Outcomes Among Disaggregated Asian Subgroups: a 2006-2020 SEER Analysis.Digestive diseases and sciences · 2026Observational
- A clinicopathological and hematological biomarker-based nomogram for overall survival in early-onset colorectal cancer: development, external validation, and translational implications.Translational cancer research · 2026Article
- Medicaid Expansion and Mortality Among Patients With Colorectal Cancer.JAMA network open · 2026Article
- Global landscape and temporal trends in lifetime risk of colorectal cancer in 185 countries: a population-based study.Cancer biology & medicine · 2026Article
- The rapid surge of colorectal cancer in children and young adults: a 22-year analysis of the CDC WONDER database.Proceedings (Baylor University. Medical Center) · 2026Article
- Race and Socioeconomic Status Impact Survival from Early and Late-Onset Colorectal Cancer.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Rates of metastatic colorectal cancer (mCRC) are rising among young adults. Disparities by race and ethnicity and neighborhood-level socioeconomic status (SES) among this population are understudied. Objective: To examine the association of race and ethnicity and neighborhood-level SES with mortality among a community-based sample of young adults with mCRC. Design, Setting, and Participants: This cohort study used a large electronic health record-derived database of young adults with cancer treated at 280 community-based US clinics between 2013 and 2021. Eligible patients were young adults aged 18 to 49 years diagnosed with de novo or recurrent mCRC. Patients were followed up until December 31, 2022. Data were analyzed from February 2024 to November 2025. Exposures: Race and ethnicity and neighborhood-level SES. Neighborhood-level SES was derived using census block group (2010 Census boundaries) and most recent address in the electronic health record. Five-year estimates from the American Community Survey (2015-2019) were used to compute the Yost Index, a composite measure of 7 variables that capture different aspects of neighborhood-level SES. Main Outcome and Measure: All-cause mortality and 1-, 2-, and 3-year survival from diagnosis. Survival was defined from date of de novo or recurrent mCRC diagnosis to date of death or December 31, 2022. Results: A total of 3115 young adults diagnosed with mCRC (mean [SD] age at diagnosis, 42.4 [5.9] years; 122 Asian [3.9%], 424 Black [13.6%], 395 Hispanic [12.7%], 1874 White [60.2%]; 1651 male [53.0%]). Survival differed significantly by race and ethnicity and neighborhood-level SES. At 3 years after diagnosis, Black patients had worse survival (41%; 95% CI, 36%-46%), while Asian (58%; 95% CI, 48%-66%) and Hispanic (53%; 95% CI, 48%-58%) patients had better survival compared with White patients (47%; 95% CI, 45%-49%). For neighborhood-level SES, 3-year survival was 41% (95% CI, 36%-45%) for patients in the lowest compared with 59% (95% CI, 54%-63%) in the highest quintile. In adjusted analyses, neighborhood-level SES was associated with mortality (Q1 vs Q5: hazard ratio [HR], 1.51; 95% CI, 1.24-1.82), while the HR for Black race and mortality was greater than 1 but not statistically significant (HR, 1.08; 95% CI, 0.90-1.31). Conclusions: In this cohort study of young adults with mCRC, 3-year survival differed by race and ethnicity and neighborhood-level SES, but only the association between neighborhood-level SES and survival remained statistically significant after adjusting for covariates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.